-
Allergy & Clinical Immunology -
Cardiovascular Medicine -
Gastroenterology & Hepatology -
General Medicine -
Genetic Medicine -
Geriatric & Palliative Medicine -
Hematology & Oncology -
Hospital Medicine -
Infectious Diseases -
Metabolism, Endocrinology & Diabetes -
Nephrology -
Pulmonary & Critical Care Medicine -
Rheumatology
Hematology & Oncology
Division of Hematology & Oncology
Highly committed to excellence in patient care, teaching and research for cancer and hematologic disorders.
On the Leading Edge of Excellence
The Division of Hematology and Oncology is the largest subspecialty division within the University of Michigan Medical School’s Department of Internal Medicine. Our physicians, researchers, staff, trainees, and laboratory teams work hand in hand across the medical campus to advance the prevention, diagnosis, and treatment of cancer and blood disorders. We strive to provide compassionate, cutting-edge care to our patients, educate future health care leaders, and discover more effective and less toxic therapies to improve patients’ survival and quality of life.
Join Our Team
The Division of Hematology and Oncology is the largest subspecialty unit in the Department of Internal Medicine, and welcomes eligible applicants to join our fantastic team.
Nationally Ranked in Cancer Care
U-M Health has been recognized as one of the nation's top hospitals for cancer care by U.S. News & World Report for 2026-2027.
See Where Training Takes Place
Expand your career trajectory in a high-volume academic medical center that also supports and excels in a wide range of basic science, translational and clinical research programs.
CME Courses
View a list of upcoming Continuing Medical Education (CME) opportunities available through the Department of Internal Medicine.
Featured News & Stories
7 Internal Medicine Specialties Nationally Recognized in USNWR Rankings
Social, financial barriers linked to reduced treatment for dangerous blood clots
The Future of Cell and Gene Therapies
Gifts advance colon cancer prevention and early detection
Phase 1 trial of alrizomadlin shows promise in targeting metastatic salivary gland cancers
Thriving after a rectal cancer diagnosis
Hematology & Oncology Internal Website
Resources and information for current Hematology & Oncology faculty, staff and learners.